Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : RMGG -- Ignore unavailable to you. Want to Upgrade?

To: Major Tom who wrote (911)	4/12/1999 2:35:00 PM
From: AKAPAK	Read Replies (1) \| Respond to of 1170

TODAY'S NEWS: NEWS RELEASE April 12, 1999 Rocky Mountain Ginseng, Inc. (OTCBB: RMGG) is pleased to announce that their subsidiary have begun promoting their existing (FF Co.) product lines in China under their new name, "Rocky Mountain Fuzhou Drug Company Ltd." Their first promotion successfully held this past weekend was located at various multi-outlet department stores. Plans are underway to attend an exhibition in Nan Ning City, the capital city of Guang Xi province (in the Southern part of China) from April 28 through to May 2. The current packaging of the existing product line (formerly FF Co.'s) is being redesigned in North America to give a more modern image and reflect the North American concept. Meanwhile, Chinese officials have approved the bar codes required under the new name, "Rocky Mountain Fuzhou Drug Company Ltd." The preparations of the new GMP ("Good Manufacturing Practices") factory are progressing as planned. The design engineer is currently working on the factory layout. Meanwhile, Rocky Mountain Ginseng, Inc. has recently purchased honey processing equipment to be shipped to China for inclusion in the new factory. Robert L. Bell, CEO, will leave for China the week of April 18th in order to inspect the new facilities and to meet with various government officials. Mr. Bell will also meet in China with a representative of a European pharmaceutical distributor to discuss the opportunities available to them for the approved pharmaceutical products in China. For further information and updates, please send us your e-mail address to rlbell@direct.ca or visit our website at www.direct.ca/ginseng. The statements made in this news release may contain certain forward looking statements. Actual events or results may differ from the Company'sexpectations. Certain risk factors may also affect the results achieved by the Company.